Ocular Therapeutix Announces Board of Directors and Leadership Updates

By Staff
Friday, February 23, 2024 12:24 AM BEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of therapies for diseases and conditions of the eye, has announced board of directors and leadership updates. Pravin U. Dugel, MD has been named executive chairman, and Jeffrey S. Heier, MD, Peter K. Kaiser, MD, and Sanjay Nayak, MBBS, PhD have been appointed to the ocular management team as chief scientific officer, medical director, and chief strategy officer, respectively.

XP Health Partners With Bell Bank, Adds Cynthia Spitalny as CMO

By Staff
Friday, February 23, 2024 12:15 AM SAN CARLOS, Calif.—XP Health, a company dedicated to democratizing vision care with a digital-first vision benefits platform, announced a new partnership with Bell Bank and the addition of new chief marketing officer Cynthia Spitalny to grow its leadership roster.

Dynamic and Comprehensive VisionEd Conference Program Announced for Vision Expo East 2024

By Staff
Thursday, February 22, 2024 12:27 AM ALEXANDRIA, Va.—The Vision Council and RX, co-organizers of Vision Expo, are gearing up to bring compelling, accredited continuing education offerings to the industry at Vision Expo East 2024. The comprehensive VisionEd optometry and opticianry program will kick off on Thursday, March 14, one day prior to the celebratory exhibit hall opening on Friday, March 15 and will run through Sunday, March 17. “The VisionEd program at Vision Expo East 2024 is a testament to our commitment to advancing the eyecare industry through a strong education program that has been created by industry, for industry,” said Fran Pennella, vice president, Vision Expo at RX.

Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor

By Staff
Thursday, February 22, 2024 12:15 AM MELBOURNE, Australia—Opthea Limited, a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced the appointment of Arshad M. Khanani, MD, MA, FASRS, as chief medical advisor.

Ocular Therapeutix Appoints Steve Meyers to Chief Commercial Officer

By Staff
Tuesday, February 20, 2024 12:24 AM BEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced the appointment of Steve Meyers as chief commercial officer. Meyers has over 20 years of commercial experience, including several buy and bill, specialty pharmacy and innovative technology product launches in highly competitive markets.

Ocuphire Pharma Strengthens Leadership Team With Key Appointments

By Staff
Tuesday, February 20, 2024 12:15 AM FARMINGTON HILLS, Mich.—Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, announced the appointments of Ash Jayagopal, Ph.D., MBA as chief scientific and development officer, and Nirav Jhaveri, CFA, MBA as chief financial officer.

EssilorLuxottica Board of Directors Proposes Nominees to the New Board

By Staff
Friday, February 16, 2024 12:21 AM CHARENTON-LE-PONT, France—EssilorLuxottica's board of directors has decided to propose the reappointment of all current directors to the next annual general meeting to be held on April 30, 2024.

Foundation Fighting Blindness to Honor L'Amy America's Stephen Rappoport and PSK Supermarket's Noah Katz at 2024 Night for Sight Gala on May 9

By Staff
Thursday, February 15, 2024 12:24 AM COLUMBIA, Md.—To raise awareness and fund research leading to treatments and cures for blinding retinal diseases, Foundation Fighting Blindness (FFB), a driving force in the global development of treatments and cures for blinding diseases, will present its prestigious Visionary Award to Stephen Rappoport, CEO of L'Amy America and Noah Katz, president and CEO of PSK Supermarkets, at its annual gala, Night for Sight. Taking place on Thursday, May 9 at 6:00 p.m. ET at The Lighthouse at Chelsea Piers in Manhattan, Night for Sight will celebrate beacons of the fashion, food and finance industries as well as the blindness community.

Vision Expo East 2024 to Welcome Back the Italian Trade Commission and 18 Coveted Designers

By Staff
Thursday, February 15, 2024 12:18 AM ALEXANDRIA, Va.—The Vision Council and RX, co-owners of Vision Expo, announced the return of the Italian Trade Commission to Vision Expo East 2024, taking place from March 14-17 at the Javits Center in New York City.

Bollé Safety Names Ellena Wong Vice President of Sales, North America and Latin America

By Staff
Thursday, February 15, 2024 12:15 AM CARLSBAD, Calif.—Bollé Safety is continuing its efforts to expand its presence in the North American market with additional key appointments, most recently announcing the appointment of Ellena Wong to the position of VP of sales for North America and Latin America markets.

Transitions Optical Announces Winners of 2024 Transitions Innovation Awards

By Staff
Wednesday, February 14, 2024 12:24 AM PINELLAS PARK, Fla.—On Tuesday evening at Transitions Academy 2024, Transitions Optical named the winners for its annual Transitions Innovation Awards program, which recognizes both individuals and organizations who have shown the highest levels of commitment to innovating their businesses over the past year. Drew Smith, senior director, North America Key Accounts, Transitions Optical, said, “The commitment and remarkable achievements from the 2024 Transitions Innovation Award winners have not only earned them well-deserved recognition, but have also helped elevate the industry. We are privileged to have them as award winners and champions of our brand, and we congratulate them on their outstanding success.”

Thomas Bender Joins MediPrint Ophthalmics as Strategic Advisor

By Staff
Wednesday, February 14, 2024 12:18 AM SAN DIEGO—MediPrint Ophthalmics, a clinical stage ophthalmic company focused on transforming the delivery of ophthalmic pharmaceuticals, announced the appointment of Thomas Bender as a strategic advisor.

National Vision Appoints Susan O’Farrell to Board of Directors

By Staff
Monday, February 12, 2024 12:15 AM DULUTH, Ga.—National Vision Holdings, Inc. announced the appointment of Susan O’Farrell to its board of directors and as a member of its audit committee. O’Farrell is an accomplished financial expert with over 35 years of executive and senior leadership experiene.

The Atelier at Vision Expo East Sells Out With Over 75 Independent, Sought-After Designers

By Staff
Friday, February 9, 2024 12:18 AM ALEXANDRIA, Va.—The Atelier at Vision Expo East 2024, a large collection of sought-after international independent designers and home to a diverse community of the industry’s leading design-led brands, will be making an enhanced, expanded and sold-out return to Vision Expo East 2024.

Mido Sees 11 Percent Rise in Attendees, Welcoming Over 40,000 From 160 Countries

By Staff
Thursday, February 8, 2024 12:21 AM MILAN—The 2024 edition of Mido concluded on February 5 with a total attendance of over 40,000 attendees during the three-day show, an 11 percent gain over last year. Mido reports that this upswing was equally distributed among Italian and international participants from 160 countries across Asia and Europe, as well as the U.S. Mido president Giovanni Vitaloni said, “Prior to the show opening, we had hoped for an increase in visitors compared to last year. Thanks to everyone’s efforts and the industry’s trust in us each year, we achieved the ambitious goal we had set for ourselves.